Compare IDYA & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | AKR |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2019 | 1996 |
| Metric | IDYA | AKR |
|---|---|---|
| Price | $34.91 | $21.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $52.86 | $22.25 |
| AVG Volume (30 Days) | 1.2M | ★ 1.6M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.69% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $218,710,000.00 | ★ $410,757,000.00 |
| Revenue This Year | N/A | $3.21 |
| Revenue Next Year | $201.05 | $12.17 |
| P/E Ratio | ★ N/A | $96.59 |
| Revenue Growth | ★ 3024.43 | 14.20 |
| 52 Week Low | $20.50 | $18.04 |
| 52 Week High | $39.28 | $22.90 |
| Indicator | IDYA | AKR |
|---|---|---|
| Relative Strength Index (RSI) | 69.60 | 49.07 |
| Support Level | $32.85 | $19.81 |
| Resistance Level | $36.01 | $22.32 |
| Average True Range (ATR) | 1.80 | 0.45 |
| MACD | 0.67 | -0.11 |
| Stochastic Oscillator | 92.17 | 32.22 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.